Biocause Pharma(SZ:000627) Bei Jing Shang Bao·2025-08-06 21:59Group 1 - The core point of the article is that *ST Tianmao (000627) announced the receipt of a letter from its controlling shareholder, Xinyi Group, regarding the planning of a significant matter, leading to a temporary suspension of its stock trading [2] - The stock of *ST Tianmao will be suspended from trading starting August 7, with an expected suspension period of no more than two trading days [2] - During the suspension, the company will fulfill its information disclosure obligations in accordance with relevant laws and regulations, and will announce the resumption of trading once the matter is confirmed [2] Group 2 - As of the market close on August 6, *ST Tianmao's stock price was reported at 1.45 yuan per share, with a total market capitalization of 7.111 billion yuan [3]